rs34425379
Variant summary
Our verdict is Likely benign. Variant got -5 ACMG points: 0P and 5B. BP4_StrongBP6
The NM_001379286.1(ZNF423):c.1655G>T(p.Gly552Val) variant causes a missense change involving the alteration of a conserved nucleotide. The variant allele was found at a frequency of 0.000258 in 1,614,024 control chromosomes in the GnomAD database, including 2 homozygotes. In-silico tool predicts a benign outcome for this variant. 12/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars).
Frequency
Consequence
NM_001379286.1 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -5 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
ZNF423 | NM_001379286.1 | c.1655G>T | p.Gly552Val | missense_variant | Exon 4 of 8 | ENST00000563137.7 | NP_001366215.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
ZNF423 | ENST00000563137.7 | c.1655G>T | p.Gly552Val | missense_variant | Exon 4 of 8 | 5 | NM_001379286.1 | ENSP00000455588.3 |
Frequencies
GnomAD3 genomes AF: 0.00143 AC: 218AN: 152040Hom.: 1 Cov.: 33
GnomAD3 exomes AF: 0.000370 AC: 93AN: 251346Hom.: 0 AF XY: 0.000235 AC XY: 32AN XY: 135882
GnomAD4 exome AF: 0.000134 AC: 196AN: 1461866Hom.: 1 Cov.: 39 AF XY: 0.000120 AC XY: 87AN XY: 727228
GnomAD4 genome AF: 0.00145 AC: 221AN: 152158Hom.: 1 Cov.: 33 AF XY: 0.00141 AC XY: 105AN XY: 74394
ClinVar
Submissions by phenotype
not provided Uncertain:2
The ZNF423 p.Gly427Val variant was not identified in the literature but was identified in dbSNP (ID: rs34425379), LOVD 3.0 and ClinVar (classified as uncertain significance by EGL Genetic Diagnostics and as likely benign by Invitae). The variant was identified in control databases in 136 of 282704 chromosomes at a frequency of 0.0004811 increasing the likelihood this could be a low frequency benign variant (Genome Aggregation Database March 6, 2019, v2.1.1). The variant was observed in the following populations: African in 116 of 24916 chromosomes (freq: 0.004656), Other in 4 of 7216 chromosomes (freq: 0.000554), Latino in 14 of 35438 chromosomes (freq: 0.000395) and European (non-Finnish) in 2 of 129102 chromosomes (freq: 0.000015), but was not observed in the Ashkenazi Jewish, East Asian, European (Finnish), or South Asian populations. The p.Gly427 residue is conserved in mammals and computational analyses (PolyPhen-2, SIFT, AlignGVGD, BLOSUM, MutationTaster) provide inconsistent predictions regarding the impact to the protein; this information is not very predictive of pathogenicity. The variant occurs outside of the splicing consensus sequence however three of four in silico or computational prediction software programs (SpliceSiteFinder, MaxEntScan, NNSPLICE, GeneSplicer) predict a greater than 10% difference in splicing and the creation of a new 5' splice site. However, this has not been confirmed by RNA analysis and is not predictive enough to assume pathogenicity. In summary, based on the above information the clinical significance of this variant cannot be determined with certainty at this time. This variant is classified as a variant of uncertain significance. -
- -
Nephronophthisis 14 Benign:1
- -
ZNF423-related disorder Benign:1
This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at